From January 1, 2024 to March 31, 2024, the company has repurchased 10,434,700 shares, representing 0.94% for CNY 166.48 million. With this, the company has completed the repurchase of 10,546,300 shares, representing 0.95% for CNY 168.33 million under the buyback announced on December 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.08 CNY | +0.13% |
|
-0.07% | -11.35% |
Jun. 15 | Shandong Buchang Pharmaceuticals Co., Ltd. announces an Increase in Equity Buyback. | CI |
May. 29 | Shandong Buchang Pharmaceuticals Gets China Nod for Cholesterol Control Tablets | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.35% | 2.27B | |
+7.30% | 4.81B | |
-31.08% | 3.6B | |
-0.71% | 3.09B | |
-24.32% | 2.62B | |
+34.19% | 1.82B | |
+33.49% | 1.41B | |
-15.07% | 1.38B | |
+40.95% | 1.37B | |
-25.94% | 1.29B |
- Stock Market
- Equities
- 603858 Stock
- News Shandong Buchang Pharmaceuticals Co., Ltd.
- Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.